Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 135

1.

Effect of food on the pharmacokinetic profile of trans-resveratrol.

Vaz-da-Silva M, Loureiro AI, Falcao A, Nunes T, Rocha JF, Fernandes-Lopes C, Soares E, Wright L, Almeida L, Soares-da-Silva P.

Int J Clin Pharmacol Ther. 2008 Nov;46(11):564-70.

PMID:
19000554
2.

Effects of food intake on the pharmacokinetic properties of mirabegron oral controlled-absorption system: a single-dose, randomized, crossover study in healthy adults.

Lee J, Zhang W, Moy S, Kowalski D, Kerbusch V, van Gelderen M, Sawamoto T, Grunenberg N, Keirns J.

Clin Ther. 2013 Mar;35(3):333-41. doi: 10.1016/j.clinthera.2013.02.014.

PMID:
23497763
4.

Abacavir/lamivudine/zidovudine as a combined formulation tablet: bioequivalence compared with each component administered concurrently and the effect of food on absorption.

Yuen GJ, Lou Y, Thompson NF, Otto VR, Allsup TL, Mahony WB, Hutman HW.

J Clin Pharmacol. 2001 Mar;41(3):277-88.

PMID:
11269568
5.

Bioavailability of a co-formulated combination of amodiaquine and artesunate under fed and fasted conditions. A randomised, open-label crossover study.

Fitoussi S, Thang C, Lesauvage E, Barré J, Charron B, Filali-Ansary A, Lameyre V.

Arzneimittelforschung. 2009;59(7):370-6. doi: 10.1055/s-0031-1296410.

PMID:
19728565
6.

Effect of food on the pharmacokinetic profile of eslicarbazepine acetate (BIA 2-093).

Maia J, Vaz-da-Silva M, Almeida L, Falcão A, Silveira P, Guimarães S, Graziela P, Soares-da-Silva P.

Drugs R D. 2005;6(4):201-6.

PMID:
15991880
7.

Pharmacokinetic and safety profile of rupatadine when coadministered with azithromycin at steady-state levels: a randomized, open-label, two-way, crossover, Phase I study.

Solans A, Izquierdo I, Donado E, Antonijoan R, Peña J, Nadal T, Carbó ML, Merlos M, Barbanoj M.

Clin Ther. 2008 Sep;30(9):1639-50. doi: 10.1016/j.clinthera.2008.09.002.

PMID:
18840369
8.

Effects of food and sucralfate on a single oral dose of 500 milligrams of levofloxacin in healthy subjects.

Lee LJ, Hafkin B, Lee ID, Hoh J, Dix R.

Antimicrob Agents Chemother. 1997 Oct;41(10):2196-200.

9.

Effects of Food Intake on the Relative Bioavailability of Amifampridine Phosphate Salt in Healthy Adults.

Haroldsen PE, Musson DG, Hanson B, Quartel A, O'Neill CA.

Clin Ther. 2015 Jul 1;37(7):1555-63. doi: 10.1016/j.clinthera.2015.05.498. Epub 2015 Jun 20.

10.

Clinical development of an everolimus pediatric formulation: relative bioavailability, food effect, and steady-state pharmacokinetics.

Kovarik JM, Noe A, Berthier S, McMahon L, Langholff WK, Marion AS, Hoyer PF, Ettenger R, Rordorf C.

J Clin Pharmacol. 2003 Feb;43(2):141-7.

PMID:
12616666
11.
12.

Effect of food on everolimus absorption: quantification in healthy subjects and a confirmatory screening in patients with renal transplants.

Kovarik JM, Hartmann S, Figueiredo J, Rordorf C, Golor G, Lison A, Budde K, Neumayer HH.

Pharmacotherapy. 2002 Feb;22(2):154-9.

PMID:
11837553
13.

Lamivudine/zidovudine as a combined formulation tablet: bioequivalence compared with lamivudine and zidovudine administered concurrently and the effect of food on absorption.

Moore KH, Shaw S, Laurent AL, Lloyd P, Duncan B, Morris DM, O'Mara MJ, Pakes GE.

J Clin Pharmacol. 1999 Jun;39(6):593-605.

PMID:
10354963
14.

The relative bioavailability study and fasting and fed states pharmacokinetics of bicalutamide 50-mg tablets in healthy Chinese volunteers.

Lu HM, Ye M.

Arzneimittelforschung. 2012 Jan;62(1):18-21. doi: 10.1055/s-0031-1295429. Epub 2012 Jan 10.

PMID:
22331758
16.

Effect of eslicarbazepine acetate on the pharmacokinetics of metformin in healthy subjects.

Rocha JF, Vaz-da-Silva M, Almeida L, Falcão A, Nunes T, Santos AT, Martins F, Fontes-Ribeiro C, Macedo T, Soares-da-Silva P.

Int J Clin Pharmacol Ther. 2009 Apr;47(4):255-61.

PMID:
19356391
17.

The effect of food on the absorption of oral ziprasidone.

Miceli JJ, Glue P, Alderman J, Wilner K.

Psychopharmacol Bull. 2007;40(3):58-68.

PMID:
18007569
18.

Effect of food on the pharmacokinetics and pharmacodynamics of R1663, an oral factor Xa inhibitor, in healthy male volunteers.

Schmitt C, Charoin-Pannier A, McIntyre C, Zandt H, Ciorciaro C, Zweigler L, Winters K, Pepper T.

Int J Clin Pharmacol Ther. 2012 Aug;50(8):566-72. doi: 10.5414/CP201697.

PMID:
22735461
19.

The pharmacokinetic parameters of a single dose of a novel nano-formulated, lower-dose oral diclofenac.

Manvelian G, Daniels S, Gibofsky A.

Postgrad Med. 2012 Jan;124(1):117-23. doi: 10.3810/pgm.2012.01.2524.

PMID:
22314121

Supplemental Content

Support Center